Cargando…
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
Ocular posterior segment diseases such as uveitis, X-linked juvenile retinoschisis, or age-related macular degeneration usually result in progressive and irreversible vision loss. Although intravitreal injection is the main way to deliver drugs to the posterior eye, it still has shortcomings as an i...
Autores principales: | Jiang, Hui, Xu, Zhuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193918/ https://www.ncbi.nlm.nih.gov/pubmed/37194147 http://dx.doi.org/10.1080/10717544.2023.2204206 |
Ejemplares similares
-
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment
por: Gabai, Andrea, et al.
Publicado: (2023) -
Ciprofloxacin-Loaded Zein/Hyaluronic Acid Nanoparticles for Ocular Mucosa Delivery
por: Jacinto, Telma A., et al.
Publicado: (2022) -
Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye
por: Tsai, Cheng-Han, et al.
Publicado: (2022) -
Hyaluronic Acid: Its Versatile Use in Ocular Drug Delivery with a Specific Focus on Hyaluronic Acid-Based Polyelectrolyte Complexes
por: Casey-Power, Saoirse, et al.
Publicado: (2022) -
Hyaluronic Acid-Chitosan Nanoparticles to Deliver Gd-DTPA for MR Cancer Imaging
por: Zhang, Li, et al.
Publicado: (2015)